We recently published a list of Gold, Biopharma Firms Dominate Friday’s 10 Top Performing Stocks. In this article, we are going to take a look at where Certara Inc. (NASDAQ:CERT) stands against other Friday’s top performing stocks.

The stock market finished the trading week on a positive note, wiping out earlier losses on Friday, as investors weighed the escalating trade tensions between the US and China.

Having been battered this week, Wall Street’s major indices all finished in the green, led by the Nasdaq, up 2.06 percent, followed by the S&P 500 with 1.81 percent, and the Dow Jones with 1.56 percent.

Ten companies, predominantly under the mining and biopharmaceutical sectors, mimicked gains on the back of fresh industry catalysts that boosted buying appetite. In this article, let us explore Friday’s top performers and the reasons behind their gains.

To come up with the list, we considered only the stocks with a $2 billion market capitalization and $5 million trading volume.

Certara Inc. (NASDAQ:CERT)

Certara Inc. surged by 22.84 percent on Friday, a third straight day, as investors bought up on its recent release of a new version of the Simcyp Simulator to support physiologically-based pharmacokinetic (PBPK) modeling, which can forecast the behavior of drugs in various body tissues.

According to CERT, the latest version would strengthen its position as a leader in the PBPK modeling in drug development and regulatory decision-making.

In the fourth quarter of 2024, CERT swung to a net income of $6.6 million from a net loss of $12.5 million in the same period a year earlier. Revenues increased by 14 percent to $100.4 million from $88 million year-on-year.

For this year, CERT expects revenues to settle between $415 million and $425 million as well as earnings per share of $0.42 to $0.46 each.

Certara accelerates medicines using proprietary biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.

Overall, CERT ranks 2nd on our list of Friday’s top performing stocks. While we acknowledge the potential of CERT as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is as promising as CERT but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.